Mice deficient in endothelial α5 integrin are profoundly resistant to experimental ischemic stroke

Journal of Cerebral Blood Flow and Metabolism

Volumn 37, Issue 1, 2017, Pages 85-96

  Roberts, Jill ^a   De Hoog, Leon ^a   Bix, Gregory J ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

blood brain barrier; extracellular matrix; middle cerebral artery occlusion; transgenic; 5 1

Indexed keywords

ALPHA5 INTEGRIN; CLAUDIN 5; GLUCOSE; IMMUNOGLOBULIN G; OXYGEN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; CELL DEATH; COLLATERAL CIRCULATION; CONTROLLED STUDY; ENDOTHELIUM CELL; EXPERIMENTAL CEREBRAL ISCHEMIA; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VASCULARIZATION; ANIMAL; BIOSYNTHESIS; BRAIN INFARCTION; BRAIN ISCHEMIA; CEREBRAL ARTERY DISEASE; CHEMICALLY INDUCED; COMPLICATION; DISEASE MODEL; DISEASE PREDISPOSITION; GENETICS; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PHYSIOLOGY; STROKE;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN INFARCTION; BRAIN ISCHEMIA; CLAUDIN-5; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; ENDOTHELIAL CELLS; INFARCTION, MIDDLE CEREBRAL ARTERY; INTEGRIN ALPHA5; MICE; MICE, KNOCKOUT; STROKE;

EID: 85006340009     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1177/0271678X15616979     Document Type: Article

References (33)

1. Kahle MP and Bix GJ. Successfully climbing the "STAIRs": Surmounting failed translation of experimental ischemic stroke treatments. Stroke Res Treat 2012; 2012: 374098.
2. del Zoppo GJ, Sharp FR, Heiss WD, et al. Heterogeneity in the penumbra. J Cereb Blood Flow Metab 2011; 31: 1836-1851.
3. del Zoppo GJ and Milner R. Integrin-matrix interactions in the cerebral microvasculature. Arterioscler Thromb Vasc Biol 2006; 26: 1966-1975.
4. Huveneers S, Truong H and Danen HJ. Integrins: signaling, disease, and therapy. Int J Radiat Biol 2007; 83: 743-751.
5. Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 1992; 69: 11-25.
6. Yang Y and Rosenberg GA. Blood-brain barrier breakdown in acute and chronic cerebrovascular disease. Stroke 2011; 42: 3323-3328.
7. Bolton SJ, Anthony DC and Perry VH. Loss of the tight junction proteins occludin and zonula occludens-1 from cerebral vascular endothelium during neutrophil-induced blood-brain barrier breakdown in vivo. Neuroscience 1998; 86: 1245-1257.
8. Dore-Duffy P. Pericytes: pluripotent cells of the blood brain barrier. Curr Pharm Des 2008; 14: 1581-1593.
9. Willis CL, Nolan CC, Reith SN, et al. Focal astrocyte loss is followed by microvascular damage, with subsequent repair of the blood-brain barrier in the apparent absence of direct astrocytic contact. Glia 2004; 45: 325-337.
10. Baeten KM and Akassoglou K. Extracellular matrix and matrix receptors in blood-brain barrier formation and stroke. Dev Neurobiol 2011; 71: 1018-1039.
11. Huber JD, Egleton RD and Davis TP. Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier. Trends Neurosci 2001; 24: 719-725.
12. Osada T, Gu YH, Kanazawa M, et al. Interendothelial claudin-5 expression depends on cerebral endothelial cell-matrix adhesion by beta(1)-integrins. J Cereb Blood Flow Metab 2011; 31: 1972-1985.
13. Francis SE, Goh KL, Hodivala-Dilke K, et al. Central roles of alpha5beta1 integrin and fibronectin in vascular development in mouse embryos and embryoid bodies. Arterioscler Thromb Vasc Biol 2002; 22: 927-933.
14. Goh KL, Yang JT and Hynes RO. Mesodermal defects and cranial neural crest apoptosis in alpha5 integrin-null embryos. Development 1997; 124: 4309-4319.
15. Yang JT, Rayburn H and Hynes RO. Embryonic meso-dermal defects in alpha 5 integrin-deficient mice. Development 1993; 119: 1093-1105.
16. Bix GJ. Perlecan domain V therapy for stroke: a beacon of hope? ACS Chem Neurosci 2013; 4: 370-374.
17. Lee B, Clarke D, Al Ahmad A, et al. Perlecan domain V is neuroprotective and proangiogenic following ischemic stroke in rodents. J Clin Invest 2011; 121: 3005-3023.
18. Clarke DN, Al Ahmad A, Lee B, et al. Perlecan domain V induces VEGf secretion in brain endothelial cells through integrin alpha5beta1 and ERK-dependent signaling pathways. PLoS One 2012; 7: e45257.
19. Al-Ahmad AJ, Lee B, Saini M, et al. Perlecan domain V modulates astrogliosis in vitro and after focal cerebral ischemia through multiple receptors and increased nerve growth factor release. Glia 2011; 59: 1822-1840.
20. Li L, Liu F, Welser-Alves JV, et al. Upregulation of fibronectin and the alpha5beta1 and alphavbeta3 integ-rins on blood vessels within the cerebral ischemic penumbra. Exp Neurol 2012; 233: 283-291.
21. van der Flier A, Badu-Nkansah K, Whittaker CA, et al. Endothelial alpha5 and alphav integrins cooperate in remodeling of the vasculature during development. Development 2010; 137: 2439-2449.
22. Li L, Welser-Alves J, van der Flier A, et al. An angiogenic role for the alpha5beta1 integrin in promoting endothelial cell proliferation during cerebral hypoxia. Exp Neurol 2012; 237: 46-54.
23. Hasan MR, Herz J, Hermann DM, et al. Visualization of macroscopic cerebral vessel anatomy-a new and reliable technique in mice. J Neurosci Methods 2012; 204: 249-253.
24. Stroke Therapy Academic Industry R. Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke 1999; 30: 2752-2758.
25. Stoeltzing O, Liu W, Reinmuth N, et al. Inhibition of integrin alpha5beta1 function with a small peptide (ATN-161) plus continuous 5-FU infusion reduces colo-rectal liver metastases and improves survival in mice. Int J Cancer 2003; 104: 496-503.
26. Sandoval KE and Witt KA. Blood-brain barrier tight junction permeability and ischemic stroke. Neurobiol Dis 2008; 32: 200-219.
27. Du C, Hu R, Csernansky CA, et al. Very delayed infarction after mild focal cerebral ischemia: a role for apop-tosis? J Cereb Blood Flow Metab 1996; 16: 195-201.
28. Weston RM, Jones NM, Jarrott B, et al. Inflammatory cell infiltration after endothelin-1-induced cerebral ischemia: histochemical and myeloperoxidase correlation with temporal changes in brain injury. J Cereb Blood Flow Metab 2007; 27: 100-114.
29. Benedek A, Moricz K, Juranyi Z, et al. Use of TTC staining for the evaluation of tissue injury in the early phases of reperfusion after focal cerebral ischemia in rats. Brain Res 2006; 1116: 159-165.
30. Milner R, Hung S, Erokwu B, et al. Increased expression of fibronectin and the alpha 5 beta 1 integrin in angio-genic cerebral blood vessels of mice subject to hypobaric hypoxia. Mol Cell Neurosci 2008; 38: 43-52.
31. Kasirer-Friede A, Kahn ML and Shattil SJ. Platelet integrins and immunoreceptors. Immunol Rev 2007; 218: 247-264.
32. Loeser RF. Integrins and cell signaling in chondrocytes. Biorheology 2002; 39: 119-124.
33. Veine DM, Yao H, Stafford DR, et al. A D-amino acid containing peptide as a potent, noncovalent inhibitor of alpha5beta1 integrin in human prostate cancer invasion and lung colonization. Clin Exp Metastasis. Epub ahead of print 25 January 2014. DOI: 10.1007/s10585-013-9634-1.